Schaeffer's Trading Floor Blog

Buzz Stocks: Humana, Goldman Sachs, Kraft Foods, and Johnson & Johnson

Today's hot stocks to watch in the news include GS, KRFT, JNJ, and HUM

by 11/5/2012 8:51 AM
Stocks quoted in this article:

Stock futures are pointed lower today, amid global uncertainty and trader inertia before tomorrow's U.S. Presidential election. But meanwhile, the rest of the market goes on, with merger announcements and earnings reports. Here are some companies to watch in the news today:

  • Earnings news: Humana Inc. (NYSE:HUM) reported third-quarter net income of $2.62 per share, a nickel below year-ago figures but above analysts' estimates. Looking forward, however, the insurer expects 2012 earnings of $7.25 to $7.35 per share, above the consensus outlook for $7.14 per share. The company also announced plans to acquire Metropolitan Health Networks, Inc. (NYSE:MDF) for slightly less than $500 million (Reuters); Tesla Motors Inc (NASDAQ:TSLA) lost $1.05 per share in the third quarter, or $0.92 per share excluding items. Revenue dropped to $50.1 million. Analysts were expecting a per-share loss of $0.89 on sales of $55.7 million. (MarketWatch)

  • Goldman Sachs Group, Inc. (NYSE:GS) has trimmed its partner list by 31 down to 407 since February, although the brokerage did not disclose which partners had been eliminated. Since 2010, GS has reduced its overall workforce by 9%. (CNBC)

  • Kraft Foods Group Inc (NASDAQ:KRFT) has announced a $650 million restructuring plan to be completed by the end of 2014. The plan -- which includes some severance payouts -- is related to last month's spin-off from its parent company. (Fox Business)

  • The first Dreamliner 787 -- designed by The Boeing Company (NYSE:BA) -- took flight on Sunday, taking 219 United Continental Holdings Inc (NYSE:UAL) passengers from Houston to Chicago. The new aircraft, which is expected to be 20% more efficient than similarly sized planes, will soon be produced at a pace of 10 per month. (CNBC)

  • The U.S. Food and Drug Administration approved the use of Johnson & Johnson's (NYSE:JNJ) Xarelto medication to treat and reduce the risk of pulmonary embolisms and deep vein thrombosis. The blood thinner had already been approved for three other uses. (The Huffington Post)

  • Finally, multiple NBC sites -- including the Saturday Night Live landing page -- were hacked over the weekend, featuring the illuminating phrase, "Remember, remember the fifth of November." (Mashable)


permanent link
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT

Partner Center

© 2014 Schaeffer's Investment Research, Inc. 5151 Pfeiffer Road, Suite 250, Cincinnati, Ohio 45242 Phone: (800) 448-2080 FAX: (513) 589-3810 Int'l Callers: (513) 589-3800 Email: service@sir-inc.com

All Rights Reserved. Unauthorized reproduction of any SIR publication is strictly prohibited.

Market Data provided by QuoteMedia.com | Data delayed 15-20 minutes unless otherwise indicated.